Volta
A Call to Improve Usability, Accuracy, and Equity of Self-Testing for COVID-19 and Other Rapid Diagnostic Tests
Unknown authors
· 2023
hash_id: 17f5b048d7d9b0ca12120096753d2804848a73536b95a69a02f4bbd506fee8ca
· DOI: 10.1089/heq.2023.0020
The increasing availability of rapid diagnostic self-tests (RDSTs) for COVID-19 has played an important and increasing role during the pandemic. However, for many underserved communities, RDSTs potential benefits are offset by problems with usability, accuracy, and equity. Given the increased need for and interest in home testing for acute and chronic diseases, including COVID-19, this piece offers ways that regulatory agencies, federal public health agencies, and test developers should engage with diverse communities to ensure equity throughout test development, implementation, and evaluation. Such engagement will ensure maximum personal and public health benefits for current and future RDSTs under real-world conditions.
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… | secondary |